There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.
Podcast: Is there a single explanation that accounts for all addictive behaviors, or is the reality more complex? Under the Cortex explores.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback